Papillary lesions of the breast should be surgically excised to avoid missing a cancer

	Tweet

Certain breast lesions diagnosed as benign on core needle biopsy have cancer at surgical excision and thus should be removed, according to a study appearing in the March issue of Radiology.

“Our study shows that all papillary lesions of the breast should be surgically excised to avoid missing a cancer,” said the study’s lead author, Cecilia L. Mercado, M.D., assistant professor of radiology at New York University Medical Center in New York City.

Papillary lesions are benign growths in the duct of the breast. They comprise approximately 1 to 3 percent of all lesions sampled by core needle biopsies. Currently, the treatment of these lesions alternates between radiographic follow-up and surgical excision, and is often dependent upon physician recommendation.

"To date, the management of benign papillary lesions on core needle biopsy has been controversial and may be based on anecdotal evidence or small published studies,” Dr. Mercado said. “No definite guidelines are published for management of these lesions.”

While papillary lesions may be diagnosed as benign, they can harbor adjacent atypical ductal hyperplasia (ADH) - a condition characterized by cells of unusual size, shape, and number in the lining of the milk ducts - and ductal carcinoma in situ (DCIS), which are cancerous cells confined to the lining of the milk ducts. Left unchecked, both these conditions pose increased risk of future malignancy.

For the study, Dr. Mercado and colleagues reviewed the imaging and histologic follow-up findings in 42 patients diagnosed with benign papillary lesions after breast core needle biopsy. Forty-three biopsies were performed on the 42 patients. Of the 43 biopsies, 36 (84 percent) of the lesions were surgically removed, and seven (16 percent) received long-term imaging follow-up.

Upon surgical excision and follow-up, the diagnoses of nine of 42 patients (21.4 percent) were upgraded to ADH or DCIS. This is a much higher percentage than reported by previous studies.

“This is one of the largest series and shows statistically significant findings,” Dr. Mercado said. “The results of our study revealed a considerable upgrade rate to either ADH or DCIS at core-needle biopsy. Therefore, all benign papillary lesions of the breast should be surgically excised, since a considerable number of atypical lesions and malignant lesions could be missed.”

http://www.rsna.org

RELATED STORIES:
Case Western Reserve Receives $2.8M for Breast Cancer Research   Lymph node removal not needed for some breast cancer   Researchers identify a new breast and ovarian cancer susceptibility gene   New tool predicts women’s outcome in breast cancer   Childhood Cancer Survivors Show Inadequate Screening for Breast Cancer   Lilly bone drug cuts breast cancer risk - study   Women well informed about breast cancer, yet lacking knowledge about current treatments   Genetic approach provides new insight into trastuzumab resistance in breast cancer   Poor sleep a problem in long-term breast cancer survivors   Novel Breast Tissue Feature may Predict Woman’s Cancer Risk   Heavy girls less likely to develop breast cancer later on   Decline in Breast Cancer: Not Just Because of Hormone Therapy   Childhood radiation therapy ups breast cancer risk   V. Suzanne Klimberg, M.D. Authors Book on Breast Surgical Techniques   Researchers Identify New Cell Targets for Preventing Growth of Breast and Other Tumors   Obesity linked with poorer breast cancer outcomes   Differences observed between black and white women in use of breast cancer therapy   Breast cancer target “failing patients” in UK   Extracts of catfish caught in polluted waters cause breast cancer cells to multiply   Eisai says drug active in advanced breast cancer   Norwegian research questions benefit of mammograms   New breast cancer genetics research from McGill University, Department of Human Genetics discussed

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]